Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 607-611, April 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shonk, C. E.
Right arrow Articles by Boxer, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shonk, C. E.
Right arrow Articles by Boxer, G. E.

Enzyme Patterns in Human Tissues

IV. Comparison of Glycolytic Enzymes in Surgical Biopsies and Autopsy Specimens1

Carl E. Shonk, Hisashi Majima, Bernard J. Koven and George E. Boxer

Merck, Sharp, and Dohme Research Laboratories, Division of Merck and Company, Inc., Rahway, New Jersey (C.E.S., G.E.B.), and New Jersey College of Medicine and Dentistry, Department of Medicine, Jersey City, New Jersey (H.M., B.J.K.)

Patterns of the glycolytic and some related enzymes were measured in several human tissues obtained surgically and at autopsy. For the most part the enzyme activities were remarkably similar and, hence, when necessary, the determination of these enzymes in specimens obtained at early autopsy is justified. Phosphofructokinase activity, however, was 1/21/5 lower in the tissues obtained at autopsy. The addition of cofactors, such as adenylic acid or adenosine 3',5'-cyclic phosphate did not elevate the activity of phosphofructokinase in specimens obtained at autopsy. Since this enzyme was stable in frozen intact tissues, the loss in activity appears to have occurred prior to autopsy. The reputedly labile glyceraldehyde phosphate dehydrogenase was stable under these conditions. These results show that phosphofructokinase is the 1st enzyme in the glycolytic pathway to lose substantial activity following death.

1 This investigation was supported by the Cancer Chemotherapy National Service Center, National Cancer Institute, under the NIH, Contracts PH-43-64-883 and PH-43-62-441.

Received 7/26/65.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.